Therapeutic goods regulation
The regulatory framework reflects and upholds the Australian community’s expectations around the safety and quality of therapeutic goods on the market.
- Ying Da Wang tablets pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
- Bigger Longer More Time More Sperms capsules pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
- The Australian Border Force (ABF) and partners have seized more than five and a half million cigarette sticks and prevented hundreds of thousands of prohibited vapes and drug items from reaching the streets of Sydney.
- Therapeutic Goods (Therapeutic Vaping Goods - Transitional Manufacturer Notification Form) Approval 2024This instrument is made under regulation 97 of the Therapeutic Goods Regulations 1990.
- This instrument is made under Schedule 5A to the Therapeutic Goods Regulations 1990 and Schedule 4 to the Therapeutic Goods (Medical Devices) Regulations 2002.
- This publication outlines our plan to transition to a paperless model for Special Access Scheme (SAS) and Authorised Prescriber (AP) submissions. From 1 July 2024 we will only accept submissions via the SAS/AP Online System.
- Public notice of interim decisions on proposed amendments to the Poisons Standard - ACMS#40, ACCS#35, Joint ACMS-ACCS#32 - November 2022Interim decisions and invitation for further comment. Closing date: 3 March 2023